These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


57 related items for PubMed ID: 10775506

  • 1. pp60(cSrc) is a caspase-3 substrate and Is essential for the transformed phenotype of A431 cells.
    Karni R, Levitzki A.
    Mol Cell Biol Res Commun; 2000 Feb; 3(2):98-104. PubMed ID: 10775506
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of pp60c-Src reduces Bcl-XL expression and reverses the transformed phenotype of cells overexpressing EGF and HER-2 receptors.
    Karni R, Jove R, Levitzki A.
    Oncogene; 1999 Aug 19; 18(33):4654-62. PubMed ID: 10467412
    [Abstract] [Full Text] [Related]

  • 3. Plasminogen activator inhibitor type-1 gene expression and induced migration in TGF-beta1-stimulated smooth muscle cells is pp60(c-src)/MEK-dependent.
    Samarakoon R, Higgins CE, Higgins SP, Kutz SM, Higgins PJ.
    J Cell Physiol; 2005 Jul 19; 204(1):236-46. PubMed ID: 15622520
    [Abstract] [Full Text] [Related]

  • 4. TAE226-induced apoptosis in breast cancer cells with overexpressed Src or EGFR.
    Golubovskaya VM, Virnig C, Cance WG.
    Mol Carcinog; 2008 Mar 19; 47(3):222-34. PubMed ID: 17849451
    [Abstract] [Full Text] [Related]

  • 5. Epidermal growth factor impairs the cytochrome C/caspase-3 apoptotic pathway induced by transforming growth factor beta in rat fetal hepatocytes via a phosphoinositide 3-kinase-dependent pathway.
    Fabregat I, Herrera B, Fernández M, Alvarez AM, Sánchez A, Roncero C, Ventura JJ, Valverde AM, Benito M.
    Hepatology; 2000 Sep 19; 32(3):528-35. PubMed ID: 10960445
    [Abstract] [Full Text] [Related]

  • 6. Cisplatin-induced activation of the EGF receptor.
    Benhar M, Engelberg D, Levitzki A.
    Oncogene; 2002 Dec 12; 21(57):8723-31. PubMed ID: 12483525
    [Abstract] [Full Text] [Related]

  • 7. As2O3-induced c-Src/EGFR/ERK signaling is via Sp1 binding sites to stimulate p21WAF1/CIP1 expression in human epidermoid carcinoma A431 cells.
    Liu ZM, Huang HS.
    Cell Signal; 2006 Feb 12; 18(2):244-55. PubMed ID: 15961274
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of EGFR-mediated phosphoinositide-3-OH kinase (PI3-K) signaling and glioblastoma phenotype by signal-regulatory proteins (SIRPs).
    Wu CJ, Chen Z, Ullrich A, Greene MI, O'Rourke DM.
    Oncogene; 2000 Aug 17; 19(35):3999-4010. PubMed ID: 10962556
    [Abstract] [Full Text] [Related]

  • 9. Taiwan cobra cardiotoxin III inhibits Src kinase leading to apoptosis and cell cycle arrest of oral squamous cell carcinoma Ca9-22 cells.
    Chien CM, Chang SY, Lin KL, Chiu CC, Chang LS, Lin SR.
    Toxicon; 2010 Sep 15; 56(4):508-20. PubMed ID: 20493203
    [Abstract] [Full Text] [Related]

  • 10. Epidermal growth factor receptor regulates osteoclast differentiation and survival through cross-talking with RANK signaling.
    Yi T, Lee HL, Cha JH, Ko SI, Kim HJ, Shin HI, Woo KM, Ryoo HM, Kim GS, Baek JH.
    J Cell Physiol; 2008 Nov 15; 217(2):409-22. PubMed ID: 18543257
    [Abstract] [Full Text] [Related]

  • 11. Cisplatin-induced cell death is EGFR/src/ERK signaling dependent in mouse proximal tubule cells.
    Arany I, Megyesi JK, Kaneto H, Price PM, Safirstein RL.
    Am J Physiol Renal Physiol; 2004 Sep 15; 287(3):F543-9. PubMed ID: 15149969
    [Abstract] [Full Text] [Related]

  • 12. Combination chemotherapy of paclitaxel and cisplatin induces apoptosis with Bcl-2 phosphorylation in a cisplatin-resistant human epidermoid carcinoma cell line.
    Sawada S, Mese H, Sasaki A, Yoshioka N, Matsumura T.
    Cancer Chemother Pharmacol; 2003 Jun 15; 51(6):505-11. PubMed ID: 12709826
    [Abstract] [Full Text] [Related]

  • 13. Src family kinases and HER2 interactions in human breast cancer cell growth and survival.
    Belsches-Jablonski AP, Biscardi JS, Peavy DR, Tice DA, Romney DA, Parsons SJ.
    Oncogene; 2001 Mar 22; 20(12):1465-75. PubMed ID: 11313890
    [Abstract] [Full Text] [Related]

  • 14. SRC family kinases mediate epidermal growth factor receptor ligand cleavage, proliferation, and invasion of head and neck cancer cells.
    Zhang Q, Thomas SM, Xi S, Smithgall TE, Siegfried JM, Kamens J, Gooding WE, Grandis JR.
    Cancer Res; 2004 Sep 01; 64(17):6166-73. PubMed ID: 15342401
    [Abstract] [Full Text] [Related]

  • 15. Roles of activated Src and Stat3 signaling in melanoma tumor cell growth.
    Niu G, Bowman T, Huang M, Shivers S, Reintgen D, Daud A, Chang A, Kraker A, Jove R, Yu H.
    Oncogene; 2002 Oct 10; 21(46):7001-10. PubMed ID: 12370822
    [Abstract] [Full Text] [Related]

  • 16. The thromboxane A2 receptor activates mitogen-activated protein kinase via protein kinase C-dependent Gi coupling and Src-dependent phosphorylation of the epidermal growth factor receptor.
    Gao Y, Tang S, Zhou S, Ware JA.
    J Pharmacol Exp Ther; 2001 Feb 10; 296(2):426-33. PubMed ID: 11160627
    [Abstract] [Full Text] [Related]

  • 17. An anti-Ras cancer potential of PP1, an inhibitor specific for Src family kinases: in vitro and in vivo studies.
    He H, Hirokawa Y, Levitzki A, Maruta H.
    Cancer J; 2000 Feb 10; 6(4):243-8. PubMed ID: 11038144
    [Abstract] [Full Text] [Related]

  • 18. Neurotensin stimulates mitogenesis of prostate cancer cells through a novel c-Src/Stat5b pathway.
    Amorino GP, Deeble PD, Parsons SJ.
    Oncogene; 2007 Feb 01; 26(5):745-56. PubMed ID: 16862179
    [Abstract] [Full Text] [Related]

  • 19. Tyrosine phosphorylation of p145met mediated by EGFR and Src is required for serum-independent survival of human bladder carcinoma cells.
    Yamamoto N, Mammadova G, Song RX, Fukami Y, Sato K.
    J Cell Sci; 2006 Nov 15; 119(Pt 22):4623-33. PubMed ID: 17062641
    [Abstract] [Full Text] [Related]

  • 20. C-Src activation by ErbB2 leads to attachment-independent growth of human breast epithelial cells.
    Sheffield LG.
    Biochem Biophys Res Commun; 1998 Sep 08; 250(1):27-31. PubMed ID: 9735325
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 3.